Bergan Kdv Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Bergan Kdv Wealth Management, LLC

$999 Million
Q2 2023

A detailed history of Bergan Kdv Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bergan Kdv Wealth Management, LLC holds 235 shares of GILD stock, worth $21,194. This represents 0.0% of its overall portfolio holdings.

Number of Shares

235

Previous 440 46.59%

Holding current value

$21,194

Previous $36,000 50.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$76.01 - $86.7 $15,582 - $17,773	-205 Reduced 46.59%	235 $18,000
Q1 2023 Apr 27, 2023	BUY	$77.31 - $88.08 $10,050 - $11,450	130 Added 41.94%	440 $36,000
Q3 2022 Oct 24, 2022	SELL	$59.54 - $68.01 $13,039 - $14,894	-219 Reduced 41.4%	310 $19,000
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $8,224 - $10,306	-142 Reduced 21.16%	529 $31,000
Q4 2021 Jan 28, 2022	BUY	$64.88 - $73.64 $64 - $73	1 Added 0.15%	671 $49,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $135 - $146	2 Added 0.3%	670 $47,000
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $126 - $138	2 Added 0.3%	668 $46,000
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $120 - $136	-2 Reduced 0.3%	666 $43,000
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $30,987 - $35,308	-547 Reduced 45.02%	668 $39,000
Q3 2020 Nov 05, 2020	SELL	$62.1 - $78.08 $29,435 - $37,009	-474 Reduced 28.06%	1,215 $77,000
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $3,617 - $4,200	50 Added 3.05%	1,689 $130,000
Q1 2020 Apr 24, 2020	BUY	$62.63 - $80.22 $1,565 - $2,005	25 Added 1.55%	1,639 $123,000
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $8,688 - $9,556	-141 Reduced 8.03%	1,614 $105,000
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $337,554 - $372,600	-5,400 Reduced 75.47%	1,755 $111,000
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $17,694 - $19,842	286 Added 4.16%	7,155 $483,000
Q1 2019 May 09, 2019	SELL	$62.53 - $70.05 $468,099 - $524,394	-7,486 Reduced 52.15%	6,869 $447,000
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $131,795 - $171,983	-2,177 Reduced 13.17%	14,355 $898,000
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $17,321 - $19,177	-243 Reduced 1.45%	16,532 $1.28 Million
Q2 2018 Jul 23, 2018	BUY	$64.88 - $75.68 $93,037 - $108,525	1,434 Added 9.35%	16,775 $1.19 Million
Q1 2018 May 03, 2018	BUY	$72.84 - $88.8 $4,224 - $5,150	58 Added 0.38%	15,341 $1.16 Million
Q4 2017 Jan 16, 2018	SELL	$71.15 - $83.52 $21,985 - $25,807	-309 Reduced 1.98%	15,283 $1.1 Million
Q3 2017 Oct 18, 2017	BUY	$72.11 - $85.47 $1.12 Million - $1.33 Million	15,592	15,592 $1.26 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bergan Kdv Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bergan Kdv Wealth Management, LLC with notifications on news.

Account

Bergan Kdv Wealth Management, LLC Gilead Sciences, Inc. Transaction History